Contrasting with Dkk1, sclerostin shows an increasing trend with a decline of eGFR, independent of PTH levels [ 83 ].
← all excerpts
The Molecular Mechanisms Underlying the Systemic Effects Mediated by Parathormone in the Context of Chronic Kidney Disease.
1
—
—